Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Invest Dermatol. 2015 Feb 10;135(6):1581–1589. doi: 10.1038/jid.2015.40

Figure 2. Pentobra is bactericidal against a broad range of P. acnes strains.

Figure 2

CFU assay results for Pentobra, pen peptide and tobramycin at varying concentrations (0–26 μM) incubated with P. acnes clinical isolates (A) HL063PA2 (health-associated), (B) HL005PA1 (health-associated) (C) HL110PA4 (health-associated), (D) HL053PA2 (acne-associated), (E) HL043PA1 (acne-associated) and (F) HL110PA1 (acne-associated) for 3 h. Data from one experiment is shown and the trends in antimicrobial activity of the compounds and activity differences between compounds are representative of three independent experiments.